Skip to the content
halfrx
← All providers and medications

Contrave (naltrexone/bupropion) vs Ozempic (semaglutide, diabetes label)

Verdict

Contrave is the better choice of the two, winning on entry price (halfrx score 6.3 against 5.1).

Computed from the stored fields, so it moves when a price does. Nothing here is written by hand or by a model.

Which is cheaper, Contrave (naltrexone/bupropion) or Ozempic (semaglutide, diabetes label)?

Contrave (naltrexone/bupropion) is $99 a month all-in, read from its own page on 2026-09-22; Ozempic (semaglutide, diabetes label) is $199–$499, read from its own page on 2026-09-22. At the maintenance dose the gap is $250 a month, which is $3,349 across a year, counting 12 fills for Contrave (naltrexone/bupropion) and 13 for Ozempic (semaglutide, diabetes label). Trial weight loss was 5.4% against 6.4%, from separate trials with different populations, so the gap is not a measured difference between the two. Every axis below is computed from stored fields rather than written by hand, so the comparison moves when a price does. Both were last checked on 2026-09-22. Neither carries an FTC action, a state action, a BBB F grade or an FDA warning letter. The published formula scores them 6.3 and 5.1 out of 10, arithmetic over the same stored fields rather than an editor's preference.

Head to head

Contrave (naltrexone/bupropion) against Ozempic (semaglutide, diabetes label), one row per axis, with the side that wins each axis marked.
What decides itContrave
$99/mo
Ozempic
$199–$499/mo
Entry priceContrave (naltrexone/bupropion) is $100/mo cheaper to start — $99 against $199.✓ better here—
Regulatory and complaint riskNeither carries a lawsuit, an FDA warning letter or a supply-risk flag.tiedtied
Average weight loss in trialsContrave (naltrexone/bupropion) reports 5.4% and Ozempic (semaglutide, diabetes label) 6.4%, each from its own trial. They were not compared against each other, and the populations, durations and endpoints differ, so the higher number is not a better result — it is a different study.not comparablenot comparable

What the trials, the titration and a year actually say

AxisContraveOzempic
Mean weight loss in the cited trial5.4%6.4%
The trial that figure comes fromCOR-I on the label, 56 weeks: 5.4% mean weight loss on 32 mg/360 mg against 1.3% on placebo, intention-to-treat.No percentage of body weight appears anywhere on the Ozempic label, which has no weight-management section: its three trial sections cover glycemic control, cardiovascular outcomes and kidney outcomes, and all report weight in kilograms. This figure is worked out from the label's own kilograms — 6.4 kg lost from a 100.1 kg mean baseline at week 40 on 2 mg — and is an arithmetic step the label does not take.
Maintenance dose2 tablets twice a day0.5 mg to 2 mg once weekly
Earliest week you reach itweek 4week 5
Year one at the published price of every step$1,188$4,237

Trial percentages are quoted from the label or the named trial beside them. They are not a head-to-head result: different populations, different durations, different endpoints. That is why the comparison above scores this axis as not comparable rather than awarding it to the higher number. The year-one figures walk each titration step at its published price — Contrave has one price at every dose, so there is no step to walk — and count the fills each manufacturer bills a year: 12 for Contrave, 13 for Ozempic. The full arithmetic is published.

Read the price gap carefully: these two are not the same purchase

  • These are different molecules — naltrexone and bupropion against semaglutide — so this is a comparison of two treatments, not of two prices for one.
  • Against every medication on this site with a verified maintenance price, Contrave (naltrexone/bupropion) is the 2nd cheapest of 9 and Ozempic (semaglutide, diabetes label) the 5th — the cheapest of them all is $75.
Currax Pharmaceuticals
Contrave (naltrexone/bupropion)
6.3
$99/mo all-in
verified 2026-09-22
Weaker moleculeBoxed warning
$199–$499/mo all-in
verified 2026-09-22
Off-label for weightBoxed warning

Contrave (naltrexone/bupropion)

Pros

  • +$99 a month direct from the manufacturer's CurAccess program — below every branded GLP-1 on this site, and tied with the cheapest compounded route.[1]
  • +Oral, no injections, no refrigeration, no titration involving needles.[2]
  • +Works on appetite and reward pathways rather than gut hormones, so it is an option for people who cannot tolerate GLP-1 side effects.[3]
  • +The bupropion component may help if you also want to stop smoking or have low mood.[3]

Cons

  • −5.4% mean weight loss at 56 weeks in COR-I, the trial on its label — about a third of semaglutide and a quarter of tirzepatide.[4]
  • −Boxed warning for suicidal thoughts and behaviors from the bupropion component.[3]
  • −Contraindicated with uncontrolled hypertension, seizure disorders and opioid use — the opioid interaction matters, because naltrexone blocks opioid pain relief in an emergency.[3]
  • −Placebo arm lost 1.3%, so the drug-attributable effect is about four points rather than the headline figure.[4]

Ozempic (semaglutide, diabetes label)

Pros

  • +New self-pay patients pay $199 for the first two monthly fills on TrumpRx, through 31 December 2026, then $349 a month at 0.25 to 1 mg.[2]
  • +Identical active molecule to Wegovy.[2]
  • +If you have type 2 diabetes, this is the on-label product and the one insurance is most likely to cover.[2]

Cons

  • −Using it for weight loss without diabetes is off-label. Insurers deny it on that basis and prescribers vary in willingness.[2]
  • −Its top dose is 2 mg, against 2.4 mg for standard Wegovy and 7.2 mg for Wegovy HD; the Ozempic label reports no weight-loss percentage to set beside Wegovy's.[5]
  • −Prescribing it off-label for weight competes with diabetes patients for supply — a recurring shortage driver.[2]

Comparisons are computed from the fields on each card, not written by hand or by a model, so they change when the data does. Information only, not medical advice. halfrx may earn a commission from some links, which never changes what a comparison says.

Everything on Contrave

Everything on Ozempic

Contrave against Ozempic, answered

Is Contrave or Ozempic better for weight loss?
Contrave reports 5.4% average weight loss and Ozempic 6.4%, each from its own trial. The two were not compared against each other, so the higher figure is not a result of a head-to-head and this page does not present it as one. What is comparable is what each costs, below.
Which is cheaper, Contrave or Ozempic?
Contrave, at $99 a month against $349 — a difference of $250 a month, or $3,349 over a year counting 12 fills a year for Contrave and 13 for Ozempic. Both figures are the maintenance price rather than an introductory rate. Above the maintenance dose, the optional higher dose costs more: Ozempic at 2 mg is $499 a month.
Can you switch between Contrave and Ozempic?
They are different molecules, so this is a change of medication rather than of brand, and the one you move to is started on its own dosing schedule.
Something on this page wrong? Tell us

Please leave out anything about your own health. How a report is handled: privacy.